Late-stage Biotechnology Companies: John Sonnier – Prudential Securities
JOHN SONNIER is a Senior Biotechnology Analyst focusing on areas of
infectious disease, transfusion medicine and neuroscience. Mr. Sonnier
joined Prudential Securities in July 1999 via the acquisition of Vector
Securities International, Inc., and is now part of the Prudential Vector
Healthcare Group. Prior to joining Vector Securities International,
Inc., in 1996, he spent eight years in the pharmaceutical industry at
Johnson & Johnson and Baxter in a variety of sales, marketing and
business development roles and, most recently, as the Senior Healthcare
Planning Manager at Baxter Healthcare Corporation, Biotech Group. Mr.
Sonnier received his BS degree in Business from the University of
Southern Mississippi in 1987. Profile
TWST: At Prudential Securities, who is your client today and how is that
group of clients changing or evolving?
Mr. Sonnier: That's actually a provocative question for Prudential